Get started
Author

Sreekumar R. Kodangattil

Observed names: S. Kodangattil, Sreekumar Kodangattil
ORCID: 0009-0005-0572-6462
Observed ORCID: 0009-0005-0572-6462
OpenAlex ID: A5035612745
Second antibody modeling assessment (AMA‐II)
2014 · Juan C. Almagro, Alexey Teplyakov, et al. · Proteins Structure Function and Bioinformatics · 146
Antibody modeling assessment II. Structures and models
2014 · Alexey Teplyakov, Jinquan Luo, et al. · Proteins Structure Function and Bioinformatics · 72
Characterization of Gpr101 expression and G-protein coupling selectivity
2006 · Brian Bates, Lynn Zhang, et al. · Brain Research · 72
Affinity Maturation of a Humanized Rat Antibody for Anti-RAGE Therapy: Comprehensive Mutagenesis Reveals a High Level of Mutational Plasticity Both Inside and Outside the Complementarity-Determining Regions
2009 · William J. Finlay, Orla Cunningham, et al. · Journal of Molecular Biology · 65
IL-22R, IL-10R2, and IL-22BP Binding Sites Are Topologically Juxtaposed on Adjacent and Overlapping Surfaces of IL-22
2008 · Paul W. Wu, Jing Li, et al. · Journal of Molecular Biology · 60
Anti-CAIX BBζ CAR4/8 T cells exhibit superior efficacy in a ccRCC mouse model
2021 · Yufei Wang, Alicia Buck, et al. · Molecular Therapy — Oncolytics · 35
PDF
The functional repertoire of rabbit antibodies and antibody discovery via next-generation sequencing
2014 · Sreekumar Kodangattil, Christine Huard, et al. · mAbs · 35
PDF
Identification of Critical Amino Acid Residues for Human iNOS Functional Activity
2008 · Saule Naureckiene, Sreekumar R. Kodangattil, et al. · The Protein Journal · 6
Abstract 62: Development of dual-targeted fine-tuned immune restoring (DFIR) CAR T cell therapy for clear cell renal cell carcinoma (ccRCC)
2021 · Yufei Wang, Alicia Buck, et al. · Cancer Research · 3
Development of Antibody–Drug Conjugates Targeting L1CAM to Treat Metastatic Cancer
2026 · Jin Suk Park, Carson Kenum, et al. · Molecular Cancer Therapeutics · 2
PDF
Novel Approaches in Discovery and Design of Antibody-Based Therapeutics
2015 · Juan C. Almagro, Sreekumar Kodangattil · Elsevier eBooks · 2
223 IL-22R, IL-10R2 and IL-22BP binding sites are topologically juxtaposed on adjacent and overlapping surfaces of IL-22
2008 · Paul W. Wu, Jing Li, et al. · Cytokine · 2
Abstract 2814: Anti-CAIX Immune Restoring (IR) CAR-T cells display superior antitumor activity and reverse immunosuppressive TME in a humanized ccRCC orthotopic mouse model
2022 · Yufei Wang, Alicia Buck, et al. · Cancer Research · 1
Supplementary Figure S1 from Development of Antibody–Drug Conjugates Targeting L1CAM to Treat Metastatic Cancer
2026 · Jin Suk Park, Carson Kenum, et al.
Supplementary Table S3 from Development of Antibody–Drug Conjugates Targeting L1CAM to Treat Metastatic Cancer
2026 · Jin Suk Park, Carson Kenum, et al.
Supplementary Table S1 from Development of Antibody–Drug Conjugates Targeting L1CAM to Treat Metastatic Cancer
2026 · Jin Suk Park, Carson Kenum, et al.
Supplementary Table S2 from Development of Antibody–Drug Conjugates Targeting L1CAM to Treat Metastatic Cancer
2026 · Jin Suk Park, Carson Kenum, et al.
Supplementary Figure S2 from Development of Antibody–Drug Conjugates Targeting L1CAM to Treat Metastatic Cancer
2026 · Jin Suk Park, Carson Kenum, et al.
Supplementary Figure S3 from Development of Antibody–Drug Conjugates Targeting L1CAM to Treat Metastatic Cancer
2026 · Jin Suk Park, Carson Kenum, et al.
Supplementary Figure S4 from Development of Antibody–Drug Conjugates Targeting L1CAM to Treat Metastatic Cancer
2026 · Jin Suk Park, Carson Kenum, et al.
Data from Development of Antibody–Drug Conjugates Targeting L1CAM to Treat Metastatic Cancer
2026 · Jin Suk Park, Carson Kenum, et al.
Achieve clear cell renal cell carcinoma (CCRCC) cures through dual-targeted fine-tuned immune restoring (DFIR) CAR-T cell therapy
2021 · Y. Wang, A. Buck, et al. · Cytotherapy
Works count: 23
Citation count: 501
H-index: 7
I10-index: 7
Year
Topic
Type